Talaris Therapeutics
(NASDAQ) TALS
Talaris Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$95.20M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TALS News
TALS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Talaris Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
74
CEO
Sandeep C. Kulkarni, MD
Website
www.tourmalinebio.comHeadquarters
Louisville, KY 40202, US
TALS Financials
Key Financial Metrics (TTM)
Gross Margin
-5%
Operating Margin
-2561%
Net Income Margin
-2212%
Return on Equity
-31%
Return on Capital
-40%
Return on Assets
-33%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$89.73M
EBITDA
$89.73M
Operating Cash Flow
$77.26M
Capital Expenditure
$9.00K
Free Cash Flow
$77.27M
Cash & ST Invst.
$258.30M
Total Debt
$244.00K
Talaris Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
84
N/A
Net Income
$23.09M
-32.1%
EBITDA
$25.97M
-18.2%
Quarterly Fundamentals
Net Cash
$239.09M
-17.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$145.00K
-35.3%
Return on Assets
-32.85%
N/A
Return on Invested Capital
-39.53%
N/A
Free Cash Flow
$20.27M
-189.0%
Operating Cash Flow
$20.26M
-188.9%